AMN Healthcare (NYSE: AMN) director adds shares via RSU vesting and new grant

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

AMN Healthcare Services director Mark G. Foletta reported routine equity compensation activity. He acquired 8,325 shares of Common Stock through the vesting and exercise of Restricted Stock Units (RSUs), bringing his direct Common Stock holdings to 21,598 shares.

He also received a new grant of 8,304 RSUs, each representing a contingent right to one share of AMN Common Stock. According to the footnotes, these RSUs were granted on May 1, 2026 under the AMN Healthcare 2025 Equity Plan and vest on the earlier of one year after the grant date or the company’s 2027 Annual Meeting of Shareholders.

Insider Trade Summary

8,325 shares exercised/converted

Mixed 3 txns

Insider FOLETTA MARK G

Role null

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	8,325	$0.00	--
Grant/Award	Restricted Stock Units	8,304	$0.00	--
Exercise	Common Stock	8,325	$0.00	--

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 21,598 shares (Direct, null)

Footnotes (1)

AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026. RSUs do not have an expiration date. The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027.

Key Figures

Common Stock acquired via RSU vesting: 8,325 shares Common Stock holdings after transaction: 21,598 shares New RSU grant: 8,304 RSUs +3 more

6 metrics

Common Stock acquired via RSU vesting 8,325 shares Acquired on May 1, 2026 through RSU exercise

Common Stock holdings after transaction 21,598 shares Direct holdings following May 1, 2026 transactions

New RSU grant 8,304 RSUs Granted May 1, 2026 under AMN Healthcare 2025 Equity Plan

Underlying shares per RSU 1 share per RSU Each RSU represents one AMN Common Stock share

RSU vesting condition (new grant) Earlier of 1 year or 2027 meeting Vests on earlier of one-year anniversary or 2027 Annual Meeting

Exercised RSUs 8,325 RSUs Exercised into Common Stock on May 1, 2026

Key Terms

Restricted Stock Units, contingent right, Equity Plan, Annual Meeting of Shareholders

4 terms

Restricted Stock Units financial

"The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each RSU represents a contingent right to receive one share of AMN Common Stock."

Equity Plan financial

"The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan."

An equity plan is a company program that gives employees, executives or directors a stake in the business through stock, stock options or similar ownership awards, like handing out slices of a pie to people who help bake it. It matters to investors because these grants can motivate key personnel and align their interests with shareholders, but they also increase the number of shares over time and can dilute existing ownership and affect reported earnings.

Annual Meeting of Shareholders financial

"vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027."

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

Form 4 Insider Transactions: What Each Field Means →

05/04/2026 - 04:35 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FOLETTA MARK G

(Last)

(First)

(Middle)

2999 OLYMPUS BOULEVARD

SUITE 500

(Street)

DALLAS

TEXAS

75019

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMN HEALTHCARE SERVICES INC [ AMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/01/2026		M⁽¹⁾		8,325	A	$0	21,598	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽²⁾	05/01/2026		M			8,325	⁽³⁾	⁽⁴⁾	Common Stock	8,325	$0	0	D
Restricted Stock Units	⁽⁵⁾	05/01/2026		A		8,304		⁽⁶⁾	⁽⁴⁾	Common Stock	8,304	$0	8,304	D

Explanation of Responses:

1. AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

2. The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock

3. The RSUs identified in this row were granted on May 2, 2025 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2026.

4. RSUs do not have an expiration date.

5. The RSUs were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

6. The RSUs identified in this row were granted on May 1, 2026 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2027.

Remarks:

	/s/ Whitney M. Laughlin, as attorney-in-fact on behalf of Mark G. Foletta	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did AMN (AMN) director Mark G. Foletta report?

Mark G. Foletta reported acquiring AMN equity through routine compensation events. He received 8,304 new Restricted Stock Units and acquired 8,325 shares of Common Stock upon RSU vesting and exercise, with no sales disclosed in this filing.

How many AMN (AMN) shares does Mark G. Foletta hold after these transactions?

After these transactions, Mark G. Foletta directly holds 21,598 shares of AMN Common Stock. He also holds 8,304 Restricted Stock Units, each representing a contingent right to receive one share of AMN Common Stock in the future, subject to vesting.

What RSU grant did Mark G. Foletta receive from AMN (AMN) on May 1, 2026?

On May 1, 2026, Mark G. Foletta received a grant of 8,304 Restricted Stock Units under the AMN Healthcare 2025 Equity Plan. Each RSU entitles him to one share of AMN Common Stock upon vesting, aligning his compensation with future company performance.

When do the newly granted AMN (AMN) RSUs to Mark G. Foletta vest?

The 8,304 new RSUs granted to Mark G. Foletta vest on the earlier of the one-year anniversary of the May 1, 2026 grant date or the date of AMN Healthcare’s 2027 Annual Meeting of Shareholders, as specified in the filing footnotes.

Were any AMN (AMN) shares sold in Mark G. Foletta’s latest Form 4?

The filing shows no sales of AMN Common Stock by Mark G. Foletta. All reported transactions are classified as acquisitions, including RSU vesting into 8,325 shares of Common Stock and a new grant of 8,304 Restricted Stock Units.

What does it mean that AMN (AMN) RSUs represent a contingent right to shares?

The filing states each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. This means Foletta receives actual shares only if vesting conditions are met, typically based on continued service or time-based vesting schedules.